192 related articles for article (PubMed ID: 15084265)
21. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation.
Kloetzel PM; Ossendorp F
Curr Opin Immunol; 2004 Feb; 16(1):76-81. PubMed ID: 14734113
[TBL] [Abstract][Full Text] [Related]
22. Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation.
York IA; Bhutani N; Zendzian S; Goldberg AL; Rock KL
J Immunol; 2006 Aug; 177(3):1434-43. PubMed ID: 16849449
[TBL] [Abstract][Full Text] [Related]
23. Antigen processing by the proteasome.
Kloetzel PM
Nat Rev Mol Cell Biol; 2001 Mar; 2(3):179-87. PubMed ID: 11265247
[TBL] [Abstract][Full Text] [Related]
24. Role of proteasomes in antigen presentation.
Gaczynska M; Rock KL; Goldberg AL
Enzyme Protein; 1993; 47(4-6):354-69. PubMed ID: 7697133
[TBL] [Abstract][Full Text] [Related]
25. Role of tripeptidyl peptidase II in MHC class I antigen presentation: Biological characteristics, cellular crosstalk and signaling.
Tan Q; Ma S; Hu J; Chen X; Yu Y; Zang G; Tang Z
Biomed Pharmacother; 2016 Dec; 84():1954-1958. PubMed ID: 27829551
[TBL] [Abstract][Full Text] [Related]
26. Tripeptidyl peptidase II is dispensable for the generation of both proteasome-dependent and proteasome-independent ligands of HLA-B27 and other class I molecules.
Marcilla M; Villasevil EM; de Castro JA
Eur J Immunol; 2008 Mar; 38(3):631-9. PubMed ID: 18286573
[TBL] [Abstract][Full Text] [Related]
27. Cells adapted to the proteasome inhibitor 4-hydroxy- 5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone require enzymatically active proteasomes for continued survival.
Princiotta MF; Schubert U; Chen W; Bennink JR; Myung J; Crews CM; Yewdell JW
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):513-8. PubMed ID: 11149939
[TBL] [Abstract][Full Text] [Related]
28. Post-proteasomal and proteasome-independent generation of MHC class I ligands.
van Endert P
Cell Mol Life Sci; 2011 May; 68(9):1553-67. PubMed ID: 21390545
[TBL] [Abstract][Full Text] [Related]
29. Antigen processing by proteasomes: insights into the molecular basis of crypticity.
Djaballah H
Mol Biol Rep; 1997 Mar; 24(1-2):63-7. PubMed ID: 9228283
[TBL] [Abstract][Full Text] [Related]
30. Tripeptidyl-peptidase II: a multi-purpose peptidase.
Tomkinson B; Lindås AC
Int J Biochem Cell Biol; 2005 Oct; 37(10):1933-7. PubMed ID: 16125107
[TBL] [Abstract][Full Text] [Related]
31. Processing of two latent membrane protein 1 MHC class I epitopes requires tripeptidyl peptidase II involvement.
Diekmann J; Adamopoulou E; Beck O; Rauser G; Lurati S; Tenzer S; Einsele H; Rammensee HG; Schild H; Topp MS
J Immunol; 2009 Aug; 183(3):1587-97. PubMed ID: 19587004
[TBL] [Abstract][Full Text] [Related]
32. The proteasome activator 11 S REG (PA28) and class I antigen presentation.
Rechsteiner M; Realini C; Ustrell V
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):1-15. PubMed ID: 10600633
[TBL] [Abstract][Full Text] [Related]
33. The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides.
Goldberg AL; Cascio P; Saric T; Rock KL
Mol Immunol; 2002 Oct; 39(3-4):147-64. PubMed ID: 12200047
[TBL] [Abstract][Full Text] [Related]
34. Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I.
Reits E; Griekspoor A; Neijssen J; Groothuis T; Jalink K; van Veelen P; Janssen H; Calafat J; Drijfhout JW; Neefjes J
Immunity; 2003 Jan; 18(1):97-108. PubMed ID: 12530979
[TBL] [Abstract][Full Text] [Related]
35. Proteasomes and antigen processing.
Tanaka K; Tanahashi N; Tsurumi C; Yokota KY; Shimbara N
Adv Immunol; 1997; 64():1-38. PubMed ID: 9100978
[No Abstract] [Full Text] [Related]
36. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.
Lucchiari-Hartz M; van Endert PM; Lauvau G; Maier R; Meyerhans A; Mann D; Eichmann K; Niedermann G
J Exp Med; 2000 Jan; 191(2):239-52. PubMed ID: 10637269
[TBL] [Abstract][Full Text] [Related]
37. Antigen processing by the class I pathway.
Benham AM; Neefjes JJ
Biochem Soc Trans; 1995 Aug; 23(3):664-9. PubMed ID: 8566439
[No Abstract] [Full Text] [Related]
38. Generating MHC class I ligands from viral gene products.
Yewdell J; Antón LC; Bacik I; Schubert U; Snyder HL; Bennink JR
Immunol Rev; 1999 Dec; 172():97-108. PubMed ID: 10631940
[TBL] [Abstract][Full Text] [Related]
39. The specificity of proteasomes: impact on MHC class I processing and presentation of antigens.
Niedermann G; Geier E; Lucchiari-Hartz M; Hitziger N; Ramsperger A; Eichmann K
Immunol Rev; 1999 Dec; 172():29-48. PubMed ID: 10631935
[TBL] [Abstract][Full Text] [Related]
40. Effects of major-histocompatibility-complex-encoded subunits on the peptidase and proteolytic activities of human 20S proteasomes. Cleavage of proteins and antigenic peptides.
Ehring B; Meyer TH; Eckerskorn C; Lottspeich F; Tampé R
Eur J Biochem; 1996 Jan; 235(1-2):404-15. PubMed ID: 8631360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
